FDA Authorizes Pfizer/BioNTech And Moderna’s Bivalent COVID Shots For 6 Months Old
Today, 7:24 AM
The FDA has authorized COVID-19 shots from Moderna Inc (NASDAQ:MRNA) and Pfizer Inc (NYSE:PFE)/ BioNTech SE (NASDAQ:BNTX) targeting the original coronavirus and Omicron sub-variants…
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization For Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine In Children Under 5 Years
Today, 7:24 AM
Bivalent vaccine authorized as third 3-µg dose in the three-dose primary series
Consistent COVID-19 hospitalization rates in this age group coupled with an overall surge in respiratory illnesses among children
FDA Authorizes Updated (bivalent) Covid-19 Vaccines For Children Down To 6 Months Of Age
Today, 7:24 AM
-Reuters
UK’s Regulatory Agency Backs Pfizer/BioNTech’s COVID-19 Vaccine For Youngest Kids
Today, 7:24 AM
The Medicines and Healthcare products Regulatory Agency (MHRA) authorized the vaccine – made by Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) for children aged…
Pfizer Files Countersuit Against Moderna In Patent Litigation Over COVID-19 Vaccine
Today, 7:24 AM
-Reuters
10 Health Care Stocks With Whale Alerts In Today’s Session
Today, 7:24 AM
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
BioNTech And Ryvu Therapeutics Enter Into Global Collaboration To Develop And Commercialize Immuno-Modulatory Small Molecule Candidates
Today, 7:24 AM
The companies enter a multi-target research collaboration to develop multiple small molecule programs targeting immune modulation in cancer and potentially other disease areas based on targets selected by